The left atrial appendage: From embryology to prevention of thromboembolism

European Heart Journal

Volumn 38, Issue 12, 2017, Pages 877-887

  Patti, Giuseppe ^a   Pengo, Vittorio ^b   Marcucci, Rossella ^c   Cirillo, Plinio ^d   Renda, Giulia ^e   Santilli, Francesca ^e   Calabrò, Paolo ^f   De Caterina, Alberto Ranieri ^e,g   Cavallari, Ilaria ^a   Ricottini, Elisabetta ^a   Parato, Vito Maurizio ^h,i   Zoppellaro, Giacomo ^b   Di Gioia, Giuseppe ^a   Sedati, Pietro ^a   Cicchitti, Vincenzo ^h   Davì, Giovanni ^e   Golia, Enrica ^f   Pariggiano, Ivana ^f   Simeone, Paola ^e   Abbate, Rosanna ^c   Prisco, Domenico ^c   Zimarino, Marco ^e   Sofi, Francesco ^c,j   Andreotti, Felicita ^k   more..

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

^g G PASQUINUCCI HOSPITAL   (Italy)

^h Madonna del Soccorso Hospital   (Italy)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^j IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^k CATHOLIC UNIVERSITY   (Italy)

more..

Author keywords

Anticoagulants; Atrial fibrillation; Left atrial appendage; NOACs; Non Vitamin K antagonist oral anticoagulants; Occlusion devices; Stroke; Systemic embolism; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ATRIAL FIBRILLATION; BLOOD CLOTTING; CARDIOEMBOLIC STROKE; COMPUTER ASSISTED TOMOGRAPHY; EMBRYOLOGY; ENDOTHELIAL DYSFUNCTION; FIBRINOLYTIC THERAPY; HEART ATRIUM APPENDAGE; HUMAN; IMPLANTABLE CLIP; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TISSUE DOPPLER IMAGING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; ANATOMY AND HISTOLOGY; ARTIFICIAL EMBOLIZATION; BLOOD FLOW VELOCITY; CEREBROVASCULAR ACCIDENT; COMPLICATION; DEVICES; ECHOCARDIOGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY; PHYSIOLOGY; PROCEDURES; SEPTAL OCCLUDER; VASCULAR ENDOTHELIUM; X-RAY COMPUTED TOMOGRAPHY;

ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; SEPTAL OCCLUDER DEVICE; STROKE; THERAPEUTIC OCCLUSION; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85019198737     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw159     Document Type: Review

References (84)

1. Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol 2012;5:220-228.
2. Beigel R, Wunderlich N, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging 2014;7: 1251-1265.
3. Al-Saady NM, Obel O, Camm AJ. Left atrial appendage: structure, function and role in thromboembolism. Heart 1999;82:547-554.
4. Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Gallinghouse GJ, Burkhardt JD, Cesarani F, Scaglione M, Natale A, Gaita F. Does left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 2012;7:531-538.
5. Jue J, Winslow T, Fazio G, Redberg RF, Foster E, Schiller NB. Pulsed Doppler characterization of left atrial appendage flow. J Am Soc Echocardiogr 1993;6: 237-244.
6. Bansal M, Kasliwal R. Echocardiography for left atrial appendage structure and function. Indian Heart J 2012;64:469-475.
7. Akosah KO, Funai J, Jesse RL, Mohanty PK. Left atrial appendage contractile function in atrial fibrillation. Influence of heart rate and cardioversion to sinus rhythm. Chest 1995;107:690-696.
8. Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J 2001;22:22-36.
9. Davis CA, Rembert J, Greenfield JC. Compliance of left atrium with and without left atrium appendage. Am J Physiol 1990;259:H1006-H1008.
10. Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. Eur J Echocardiogr 2000;1:130-137.
11. von der Recke G, Schmidt H, Illien S, Luderitz B, Omran H. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion. J Am Soc Echocardiogr 2002;15: 1256-1261.
12. Karakus G, Kodali V, Inamdar V, Nanda NC, Suwanjutah T, Pothineni KR. Comparative assessment of left atrial appendage by transesophageal and combined two-and three-dimensional transthoracic echocardiography. Echocardiography 2008;25: 918-924.
13. Parvathaneni L, Mahenthiran J, Jacob S, Foltz J, Gill WJ, Ghumman W, Gradus-Pizlo I, Feigenbaum H, Sawada SG. Comparison of tissue Doppler dynamics to Doppler flow in evaluating left atrial appendage function by transesophageal echocardiography. Am J Cardiol 2005;95:1011-1014.
14. Acar J, Cormier B, Grimberg D, Kawthekar G, Iung B, Scheuer B, Farah E. Diagnosis of left atrial thrombi in mitral stenosis-usefulness of ultrasound techniques compared with other methods. Eur Heart J 1991;12 Suppl B:70-76.
15. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, Johnson RG, Douglas PS. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995;123:817-822.
16. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31: 2369-2429.
17. Kim YY, Klein AL, Halliburton SS, Popovic ZB, Kuzmiak SA, Sola S, Garcia MJ, Schoenhagen P, Natale A, Desai MY. Left atrial appendage filling defects identified by multidetector computed tomography in patients undergoing radiofrequency pulmonary vein antral isolation: a comparison with transesophageal echocardiography. Am Heart J 2007;154:1199-1205.
18. Gottlieb I, Pinheiro A, Brinker JA, Corretti MC, Mayer SA, Bluemke DA, Lima JA, Marine JE, Berger RD, Calkins H, Abraham TP, Henrikson CA. Diagnostic accuracy of arterial phase 64-slice multidetector CT angiography for left atrial appendage thrombus in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008;19:247-251.
19. Martinez MW, Kirsch J, Williamson EE, Syed IS, Feng D, Ommen S, Packer DL, Brady PA. Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation. JACC Cardiovasc Imaging. 2009;2:69-76.
20. Muellerleile K, Sultan A, Groth M, Steven D, Hoffmann B, Adam G, Lund GK, Rostock T, Willems S. Velocity encoded cardiovascular magnetic resonance to assess left atrial appendage emptying. J Cardiovasc Magn Reson 2012;14:39.
21. Akoum N, Fernandez G, Wilson B, McGann C, Kholmovski E, Marrouche N. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2013;24:1104-1109.
22. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011;22: 16-22.
23. De Caterina R, Camm AJ. What is 'valvular' atrial fibrillation? A reappraisal. Eur Heart J 2014;35:3328-3335.
24. Dasi LP, Simon HA, Sucosky P, Yoganathan AP. Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol 2009;36:225-237.
25. De Caterina R, John CammA. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial. Europace 2016;18: 6-11.
26. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
27. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-166.
28. Handke M, Harloff A, Hetzel A, Olschewski M, Bode C, Geibel A. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants, and relationship to spontaneous echocontrast and thrombus formation-a transesophageal echocardiographic study in 500 patients with cerebral ischemia. J Am Soc Echocardiogr 2005;18:1366-1372.
29. Khurram IM, Dewire J, Mager M, Maqbool F, Zimmerman SL, Zipunnikov V, Beinart R, Marine JE, Spragg DD, Berger RD, Ashikaga H, Nazarian S, Calkins H. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm 2013;10:1843-1849.
30. Ren JF, Callans DJ, Marchlinski FE. What is the natural relationship between left atrial appendage morphology and history of stroke? J Am Coll Cardiol 2013;61: 689-690.
31. Nedios S, Kornej J, Koutalas E, Bertagnolli L, Kosiuk J, Rolf S, Arya A, Sommer P, Husser D, Hindricks G, Bollmann A. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. Heart Rhythm 2014;11:2239-2246.
32. Masawa N, Yoshida Y, Joshita T, Ooneda G. Diagnosis of cardiac thrombosis in patients with atrial fibrillation in the absence of macroscopically visible thrombi. Virchows Arch A Pathol Anat Histopathol 1993;422:67-71.
33. Kumagai K, Fukuchi M, Ohta J, Baba S, Oda K, Akimoto H, Kagaya Y, Watanabe J, Tabayashi K, Shirato K. Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling. Circ J 2004;68:321-327.
34. Rastegar R, Harnick DJ, Weidemann P, Fuster V, Coller B, Badimon JJ, Chesebro J, Goldman ME. Spontaneous echocontrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. J Am Coll Cardiol 2003;41:603-610.
35. Lip GY, Lowe GD, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 1995;73:527-533.
36. Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003;90:1163-1172.
37. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106-112.
38. Atalar E, Aytemir K, Sade E, Ozer N, Kilic H, Ovunc K, Aksoyek S, Nazli N, Kes S, Kabakçi G, Kirazli S, Ozmen F. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets 2003;14:407-411.
39. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 1997;126:615-620.
40. Cresti A, Garciá-Fernández MA, De Sensi F, Miracapillo G, Picchi A, Scalese M, Severi S. Prevalence of auricular thrombosis before atrial flutter cardioversion: a 17-year transesophageal echocardiographic study. Europace 2016;18:450-456.
41. Fukuda S, Watanabe H, Shimada K, Aikawa M, Kono Y, Jissho S, Taguchi H, Umemura J, Yoshiyama M, Shiota T, Sumiyoshi T, Yoshikawa J. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation. J Cardiol 2011;58:266-277.
42. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003;145:676-682.
43. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-2747.
44. Huang G, Schaff HV, Sundt TM, Rahimtoola SH. Treatment of obstructive thrombosed prosthetic heart valve. J Am Coll Cardiol 2013;62:1731-1736.
45. Lee CH, Chen CC, Chern MS. Thrombolytic therapy for acute left atrial thrombus formation in one patient with heart failure and atrial fibrillation. Circ J 2007;71: 604-607.
46. Bechtold H, Gunzenhauser D, Sawitzki H, Fung S, Janssen D. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TOE-guided cardioversion. Z Kardiol 2003;92:532-539.
47. Akdeniz B, Türker S, Oztürk V, Badak O, Okan T, Aslan O, Kozan O, Kirimli O, Aytekin D, Bariş N, Güneri S. Cardioversion under the guidance of transesophageal echocardiography in persistent atrial fibrillation: results with low molecular weight heparin. Int J Cardiol 2005;98:49-55.
48. Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of non-rheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995;92:160-163.
49. Seidl K, Rameken M, Drögemüller A, Vater M, Brandt A, Schwacke H, Bergmeier C, Zahn R, Senges J. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002;39:1436-1442.
50. Corrado G, Tadeo G, Beretta S, Tagliagambe LM, Manzillo GF, Spata M, Santarone M. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 1999;115:140-143.
51. Scardi S, Mazzone C, Pandullo C, Goldstein D, Perkan A. A longitudinal study in patients with non-rheumatic atrial fibrillation and left atrial thrombosis treated with anticoagulant therapy. G Ital Cardiol 1997;27:1036-1043.
52. JaberWA, Prior DL, Thamilarasan M, Grimm RA, Thomas JD, Klein AL, Asher CR. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study. Am Heart J 2000;140:150-156.
53. Saeed M, Rahman A, Afzal A, Agoston I, Jammula P, Birnbaum Y, Ware DL, Uretsky BF, Schwarz ER, Rosanio S. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol 2006;113:401-405.
54. Bernhardt P, Schmidt H, Hammerstingl C, Hackenbroch M, Sommer T, Lüderitz B, Omran H. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. Am J Cardiol 2004;94:801-804.
55. Weigner MJ, Thomas LR, Patel U, Schwartz JG, Burger AJ, Douglas PS, Silverman DI, Manning WJ. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001;110:694-702.
56. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996;348:423-428.
57. Vidal A, Vanerio G. Dabigatran and left atrial appendage thrombus. J Thromb Thrombolysis 2012;34:545-547.
58. Sharma S, Singh S, Sandhu R, Monterroso M, Bhambi N, Sharma R. Case report series of left atrial thrombus formation in patients on dabigatran therapy. Am J Ther 2014;21:e71-e74.
59. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI. European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2013;109:769-786.
60. Hammerstingl C, Pö tzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013;109:583-584.
61. Takasugi J, Yamagami H, Okata T, Toyoda K, Nagatsuka K. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy. Cerebrovasc Dis 2013;36: 322-323.
62. Kawakami T, Kobayakawa H, Ohno H, Tanaka N, Ishihara H. Resolution of left atrial appendage thrombus with apixaban. Thromb J 2013;11:26.
63. Dobashi S, Fujino T, Ikeda T. Use of apixaban for an elderly patient with left atrial thrombus. BMJ Case Rep 2014; doi: 10. 1136/bcr-2014-203870.
64. Ohyagi M, Nakamura K, Watanabe M, Fujigasaki H. Embolic stroke during apixaban therapy for left atrial appendage thrombus. J Stroke Cerebrovasc Dis 2015;24: e101-e102.
65. Kanderian AS, Gillinov AM, Petterson GB, Blackston E, Klein AL. Cardiac surgery success of surgical left atrial appendage closure assessment by transoesophageal echocardiography. J Am Coll Cardiol 2008;52:924-929.
66. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288-293.
67. Garcia-Fernandez MA, Perez-David E, Quiles J, Peralta J, Garciá-Rojas I, Bermejo J, Moreno M, Silva J. Role of left atrial appendage obliteration in patients with mitral valve prosthesis. J Am Coll Cardiol 2003;42:1253-1258.
68. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003;42: 1249-1252.
69. Ailawadi G, Gerdisch MW, Harvey RL, Hooker RL, Damiano RJ Jr, Salamon T, Mack MJ. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg 2011;142:1002-1009.
70. Slater AD, Tatooles AJ, Coffey A, Pappas PS, Bresticker M, Greason K, Slaughter MS. Prospective clinical study of a novel left atrial appendage occlusion device. Ann Thorac Surg 2012;93:2035-2040.
71. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC/AHA Task Force Members. 2014 AHA/ ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary-A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014;130:2071-2074.
72. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14.
73. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non inferiority trial. Lancet 2009;374:534-542.
74. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation. J Am Med Assoc 2014;312: 1988-1998.
75. Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of theWatchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol 2014;64:1-12.
76. Tzikas A, Shakir S, Gafoor S, Omran H. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 2016;11:1170-1179.
77. Romanov A, Pokushalov E, Artemenko S, Yakubov A, Stenin I, Kretov E, Krestianinov O, Grazhdankin I, Risteski D, Karaskov A, Steinberg JS. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol 2015; 44:9-16.
78. Alipour A, Swaans MJ, van Dijk VF, Balt JC, Post MC, Bosschaert MAR, Rensing BJ, Reddy VY, Boersma LVA. Ablation for atrial fibrillation combined with left atrial appendage closure. JACCCEP 2015;1:486-495.
79. Price MJ, Gibson DN, Yakubov SJ, Schultz JC, Di Biase L, Natale A, Burkhardt JD, Pershad A, Byrne TJ, Gidney B, Aragon JR, Goldstein J, Moulton K, Patel T, Knight B, Lin AC, Valderrábano M. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U. S. transcatheter LAA ligation consortium. J Am Coll Cardiol 2014;64:565-572.
80. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-2619.
81. Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, Akl EA, Olav Vandvik P, Lansberg MG, Guyatt GH, Spencer FA. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl. ):e669S-e690S.
82. Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61:2551-2556.
83. Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fü rnkranz A, Nowak B, Schmidt B. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Heart Rhythm 2013;10: 1792-1799.
84. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S, AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806-817.